▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Sware Adds AI Assistance to Res_Q Platform, Receives SOC 2 Type II Certification

Sware, provider of the most complete software validation solution for innovative life sciences, software, and technology companies today announced that it has added AI Assistance to its Res_Q™ platf...

Business Wire

Sware’s AI-supported tools and new certification affirm company’s commitment to deliver leading-edge technology for life sciences companies supported by industry best practices

BOSTON: Sware, provider of the most complete software validation solution for innovative life sciences, software, and technology companies today announced that it has added AI Assistance to its Res_Q™ platform, a GxP validation platform that helps life sciences and biotechnology companies automate, unify, and accelerate validation processes. It comes as part of a larger, major update (24.2) that offers users multiple functional and quality-of-life changes for reporting, document review, quality assurance, and more. Additionally, the company received a System and Organizational Controls 2 Type II (SOC 2 Type II) certification following a successful external audit by Sensiba LLP, demonstrating strict systems controls in multiple domains including security, availability, and confidentiality.

Res_Q’s new AI Assistance feature helps users accelerate content creation and ensure consistency across document sets within the platform, making documentation and file management easier, faster, and more efficient. For example, a new AI-powered feature can now ingest and summarize large volumes of release notes, streamlining a core step in the validation process. The addition of AI Assistance to Res_Q is the first of several planned steps in Sware’s broader AI integration roadmap, which will focus on building Quality directly into AI-supported validation and supporting responsible use at all points in the GxP validation process.

Sware’s recently awarded SOC 2 Type II certification reflects the company’s ongoing commitment to upholding the highest quality standards possible in development, deployment, and operation. Notably, Sware’s SOC 2 Type II report did not have any noted exceptions and was therefore issued with a “clean” audit opinion from Sensiba. This indicates that Sware demonstrated an exceptionally high degree of rigor throughout the audit process.

“Sware has always strived to implement high-value features rooted in unparalleled domain knowledge and proven best practices,” said Ellen Reilly, CEO of Sware. “The addition of AI Assistance to Res_Q, in tandem with our SOC 2 Type II certification, demonstrates our capability to deliver customers leading-edge solutions backed by exceptional rigor, knowledge, and service. We look forward to announcing new functionalities, including additional AI-based capabilities, as we continue to enhance the Res_Q platform.”

About Res_Q
Res_Q is a cloud-based platform built with an open API architecture that allows life sciences organizations to control all validation processes – for IT, manufacturing, lab systems, and more – in a single, highly scalable system. With intelligent risk assessments to initiate workflows and assign workloads based on risk profile, Res_Q puts quality at the forefront without sacrificing speed.

About SOC 2 Type II
Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2 information security audit provides a report on the examination of controls relevant to the trust services criteria categories covering security, availability and confidentiality. A SOC 2 Type II report describes a service organization's systems, whether the design of specified controls meets the relevant trust services categories, and – as a follow-up to Type I – assesses the effectiveness of those controls over a specified period.

About Sware
Sware’s mission is to rescue life sciences companies from the grip of validation debt; the unpaid cost of release, testing, GxP, and business requirements. The Res_Q™ software platform offers the most complete validation solution available today. Res_Q eliminates validation debt and ensures peace of mind in an increasingly complex technology ecosystem. For more information, visit www.sware.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Keysight Launches All-In-One Solution for Network Visibility and Security

#AI--Keysight Technologies, Inc. (NYSE: KEYS) launched AppFusion, a network visibility partner program that integrates third-party security and monitoring…

AI Solutions for Visually Impaired, AI Search and AI Agents Win ISG Startup…

#AI--AI-powered solutions for addressing visual impairments, optimizing brands for AI search and creating AI agents won the ISG Startup Challenges at…

Sensormatic Solutions Extends Shrink Analyzer Capabilities ‘Beyond the…

Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), continues its mission of building smarter, more…

N-Power Medicine Acquires Syapse to Expand Its Next-Generation Community-Based…

N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”),…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!